9 days ago
KRYS
AnalystsGeulah LivshitsGeulah Livshits's Stock Forecasts
AnalystsGeulah Livshits
Sectors:
Analyst Ranking
Top 7%
#262 out of 4227 analysts
Average Return
+14.29%
Win Rate
36%36 out of 99
Risk vs Reward
Poor
Good
Geulah Livshits's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cabaletta Bio IncCABA | +489.54% | $1.53 | $9.02 | 2022-08-11 - 2023-05-26 | Strong Buy |
Provention Bio IncPRVB | +466.44% | $4.41 | $24.98 | 2022-08-04 - 2023-04-27 | Strong Buy |
Logicbio Therapeutics IncLOGC | +444.74% | $0.38 | $2.07 | 2022-08-21 - 2022-11-15 | Strong Buy |
Logicbio Therapeutics IncLOGC | +387.06% | $0.43 | $2.07 | 2022-05-16 - 2022-11-15 | Strong Buy |
Moderna IncMRNA | +323.78% | $73.00 | $309.36 | 2020-10-08 - 2021-10-07 | Strong Buy |
Geulah Livshits Analyst Color
Get additional color on Geulah Livshits's coverage of popular stocks
a month ago
IMRX
6 months ago
MRNA
8 months ago
RCKT
Geulah Livshits's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Krystal Biotech IncKRYS | 4 | Strong Buy | $148.00 | +22.84% | Maintains | 9 days ago |
Tenaya Therapeutics IncTNYA | 5 | Strong Buy | $23.00 | +229.04% | Maintains | 19 days ago |
Senti Biosciences IncSNTI | 4 | Strong Buy | $6.00 | +531.58% | Maintains | 19 days ago |
Achilles Therapeutics PLCACHL | 3 | Strong Buy | $11.00 | +988.03% | Maintains | 20 days ago |
Editas Medicine IncEDIT | 6 | Strong Buy | $22.00 | +141.76% | Reiterates | 23 days ago |
Rocket Pharmaceuticals IncRCKT | 8 | Strong Buy | $61.00 | +187.74% | Maintains | 23 days ago |
Immuneering CorpIMRX | 4 | Strong Buy | $22.00 | +239.24% | Maintains | a month ago |
Taysha Gene Therapies IncTSHA | 5 | Strong Buy | $5.00 | +614.29% | Maintains | 2 months ago |
Immatics NvIMTX | 2 | Strong Buy | $25.00 | +153.81% | Maintains | 2 months ago |
Century Therapeutics IncIPSC | 2 | Strong Buy | $19.00 | +527.06% | Reiterates | 2 months ago |
Cabaletta Bio IncCABA | 4 | Strong Buy | $12.00 | +33.04% | Reiterates | 2 months ago |
Meiragtx Holdings PLCMGTX | 3 | Strong Buy | $41.00 | +523.57% | Maintains | 2 months ago |
Provention Bio IncPRVB | 4 | Strong Buy | $25.00 | +0.08% | Maintains | 3 months ago |
Iovance Biotherapeutics IncIOVA | 5 | Strong Buy | $29.00 | +284.11% | Reiterates | 3 months ago |
Intellia Therapeutics IncNTLA | 8 | Strong Buy | $111.00 | +184.76% | Maintains | 3 months ago |
Crispr Therapeutics AgCRSP | 7 | Strong Buy | $123.00 | +90.23% | Maintains | 3 months ago |
Moderna IncMRNA | 7 | Hold | $208.00 | +64.77% | Maintains | 4 months ago |
Passage Bio IncPASG | 1 | Strong Buy | $11.00 | +982.68% | Maintains | 6 months ago |
Sqz Biotechnologies CoSQZ | 3 | Strong Buy | $4.00 | +596.86% | Maintains | 6 months ago |
Pds Biotechnology CorpPDSB | 3 | Strong Buy | $16.00 | +86.92% | Maintains | 7 months ago |
Logicbio Therapeutics IncLOGC | 4 | Strong Buy | $2.50 | +20.77% | Maintains | 9 months ago |
Solid Biosciences IncSLDB | 3 | Strong Buy | $90.00 | +1,361.04% | Maintains | 10 months ago |
Homology Medicines IncFIXX | 2 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Regenxbio IncRGNX | 1 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Hold | $4.00 | N/A | Maintains | 2 years ago |
Renovacor IncRCOR | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Vincerx Pharma IncVINC | 2 | Strong Buy | $30.00 | N/A | Maintains | 2 years ago |
Adverum Biotechnologies IncADVM | 1 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Immunome IncIMNM | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.